POCN MASH Center of Excellence – POCN MASH Center of Excellence

Metabolic Dysfunction-Associated Steatohepatitis Resources Chosen by Advanced Practice Providers

Clinical guidelines
Patient support and education resources
Research updates

Sequential NIT Screening for MASH Reduces Biopsies and Costs

This study evaluated the diagnostic performance of non-invasive tests (NITs) like the FibroScan-AST (FAST) score, LSM-VCTE, FIB-4, and NFS for screening metabolic dysfunction-associated steatohepatitis (MASH) in clinical trials....

Jennifer Geremia,

MSPAS, PA-C
Physician Associate, Brigham and Women’s Hospital
and Teaching Hospital of Harvard Medical School

Challenges of Liver Transplantation for MASLD

Liver transplantation (LT) for metabolic dysfunction-associated steatotic liver disease (MASLD) is challenging due to high comorbidity rates, including obesity, diabetes,...

CURATED BY:
Jennifer Geremia,
MSPAS, PA-C

Genetic Risk Factors for NASH-Related Hepatocellular Carcinoma

This study aimed to identify genetic risk factors driving the progression from non-alcoholic fatty liver disease (NAFLD) to non-alcoholic steatohepatitis...

CURATED BY:
Jennifer Geremia,
MSPAS, PA-C

Liver Biopsy Evaluation in MASH

During recent decades, the metabolic dysfunction-associated steatohepatitis (MASH) field has witnessed several paradigm shifts, including the recognition of liver fibrosis...

CURATED BY:
Corrie Berk,
DNP, MBA, APRN

Physician Associate and Nurse Practitioner Contributors to the Metabolic Dysfunction-Associated Steatohepatitis Center of Excellence

POCN’s Metabolic Dysfunction-Associated Steatohepatitis Center of Excellence is curated by practicing clinical physician associates and nurse practitioners who review and select resources that are the most useful to their peers. They provide their expertise by hand-picking the latest content for advanced practice providers.